Dehydroepiandrosterone (DHEA) Feeding Protects Liver Steatosis in Obese Breast Cancer Rat Model
Obesity is a major health problem in the US and globally. Obesity is associated with the risk of cardiovascular disease, type 2 diabetes, cancers, hyperlipidemia, and liver steatosis development. Dehydroepiandrosterone (DHEA) is a dietary supplement used as an anti-obesity supplement. Previously, we...
Saved in:
Main Authors: | Reza Hakkak (Author), Andrea Bell (Author), Soheila Korourian (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2017-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dehydroepiandrosterone (DHEA) adjuvant and poor ovarian responders
by: Wen-Ling Lee, et al.
Published: (2022) -
Dehydroepiandrosterone (DHEA) Improves the Metabolic and Haemostatic Disturbances in Rats with Male Hypogonadism
by: Sally M. Safwat, et al.
Published: (2022) -
Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR)
by: Gleicher Norbert, et al.
Published: (2011) -
Monoamines, BDNF, Dehydroepiandrosterone, DHEA-Sulfate, and Childhood Depression-An Animal Model Study
by: O. Malkesman, et al.
Published: (2009) -
Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS)
by: Weghofer Andrea, et al.
Published: (2010)